| 000 | 01542 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516180731.0 | ||
| 264 | 0 | _c20141212 | |
| 008 | 201412s 0 0 eng d | ||
| 022 | _a1476-5381 | ||
| 024 | 7 |
_a10.1111/bph.12512 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBenemei, S | |
| 245 | 0 | 0 |
_aThe TRPA1 channel in migraine mechanism and treatment. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cMay 2014 |
||
| 300 |
_a2552-67 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnalgesics _xtherapeutic use |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcitonin Gene-Related Peptide _xmetabolism |
| 650 | 0 | 4 |
_aCalcium Channels _xmetabolism |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 |
_aMembrane Transport Modulators _xtherapeutic use |
| 650 | 0 | 4 |
_aMigraine Disorders _xdrug therapy |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPain Perception _xdrug effects |
| 650 | 0 | 4 |
_aPain Threshold _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Calcitonin Gene-Related Peptide _xmetabolism |
| 650 | 0 | 4 | _aTRPA1 Cation Channel |
| 650 | 0 | 4 |
_aTransient Receptor Potential Channels _xantagonists & inhibitors |
| 700 | 1 | _aFusi, C | |
| 700 | 1 | _aTrevisan, Gabriela | |
| 700 | 1 | _aGeppetti, Pierangelo | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 171 _gno. 10 _gp. 2552-67 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bph.12512 _zAvailable from publisher's website |
| 999 |
_c23244788 _d23244788 |
||